{"id":74629,"date":"2013-03-20T08:59:09","date_gmt":"2013-03-20T12:59:09","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/elsevier-announces-the-launch-of-a-new-journal-wound-medicine.php"},"modified":"2013-03-20T08:59:09","modified_gmt":"2013-03-20T12:59:09","slug":"elsevier-announces-the-launch-of-a-new-journal-wound-medicine","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/medicine\/elsevier-announces-the-launch-of-a-new-journal-wound-medicine.php","title":{"rendered":"Elsevier Announces the Launch of a New Journal: Wound Medicine"},"content":{"rendered":"<p><p>    MUNICH, March 20, 2013 \/PRNewswire\/ --  <\/p>\n<p>        Elsevier, a world-leading provider of scientific, technical    and medical information products and services, is pleased to    announce the launch of Wound Medicine-The    International Wound Journal for Clinical and Health Economics    Research and Applications.  <\/p>\n<p>    Published in print and online four times a year Wound    Medicine is devoted to the clinical, scientific and health    economics aspects in the prevention, management and    reimbursement in wound care. The journal publishes original    research papers and review articles. In addition, the journal    will feature standards and guidelines, commentaries, health    economic analyses and selected conference papers that meet the    information need of wound care specialists and service    providers.  <\/p>\n<p>    Thomas Wild and Thomas Eberlein, both from the Wound Academy in    Hamburg and University Medical Center Hamburg-Eppendorf,    founded the journal. Together with a prestigious international    editorial team they aim to cover themes central to the journal    such as: tissue repair and wound healing, diabetic foot    syndrome, clinical trials and outcomes, health care and    economics and service delivery. Their vision for Wound    Medicine is to advance the translation of science into    clinical practice and application, to improve outcomes and the    patient experience.  <\/p>\n<p>    \"We are convinced that Wound Medicine will facilitate    the development of standards and enhance guidelines benefitting    health care professionals in and beyond Europe by putting    emphasis on health improvement and economic benefits,\" said    Thomas Wild, \"The journal has been launched to provide a home    for translational wound research, and we welcome submissions    from all affiliated clinical fields.\"   <\/p>\n<p>    \"We are excited about the launch of Wound Medicine which    will cover the rapidly developing area of wound care, a subject    of ever increasing importance,\" added Helen Habernickel,    Publishing Editor at Elsevier. \"Our aging and diabetes prone    population is at an increased risk of developing chronic wounds    while normal wound healing decreases with age. This journal    will provide a publication platform for the advances made in    wound research.\"  <\/p>\n<p>    For more information or to submit an article, go to:     <a href=\"http:\/\/www.elsevier.com\/journals\/wound-medicine\/2213-9095\" rel=\"nofollow\">http:\/\/www.elsevier.com\/journals\/wound-medicine\/2213-9095<\/a>  <\/p>\n<p>    # # #  <\/p>\n<p>    About Elsevier    Elsevier is a world-leading provider of scientific, technical    and medical information products and services. The company    works in partnership with the global science and health    communities to publish more than 2,000 journals, including    The Lancet and Cell, and close to 20,000 book titles, including    major reference works from Mosby and Saunders. Elsevier's    online solutions include     ScienceDirect,     Scopus,     Reaxys,     ClinicalKey and     Mosby's Nursing Suite, which enhance the productivity of    science and health professionals, and the     SciVal suite and     MEDai's Pinpoint Review, which help research and health    care institutions deliver better outcomes more    cost-effectively.  <\/p>\n<p>    A global business headquartered in Amsterdam,     Elsevier employs 7,000 people worldwide. The company is    part of     Reed Elsevier Group PLC, a world-leading provider of    professional information solutions in the Science, Medical,    Legal and Risk and Business sectors, which is jointly owned by    Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are    REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and    ENL (New York Stock Exchange).  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Go here to read the rest:<\/p>\n<p><a target=\"_blank\" href=\"http:\/\/finance.yahoo.com\/news\/elsevier-announces-launch-journal-wound-112300575.html;_ylt=AwrjgkRnsklRaQEACgD_wgt.\" title=\"Elsevier Announces the Launch of a New Journal: Wound Medicine\">Elsevier Announces the Launch of a New Journal: Wound Medicine<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> MUNICH, March 20, 2013 \/PRNewswire\/ -- Elsevier, a world-leading provider of scientific, technical and medical information products and services, is pleased to announce the launch of Wound Medicine-The International Wound Journal for Clinical and Health Economics Research and Applications.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/medicine\/elsevier-announces-the-launch-of-a-new-journal-wound-medicine.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[35],"tags":[],"class_list":["post-74629","post","type-post","status-publish","format-standard","hentry","category-medicine"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/74629"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=74629"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/74629\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=74629"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=74629"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=74629"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}